Mesterolone
규격
1424-00-6CAS 번호
215-836-3EC 번호
(1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-oneIUPAC 명칭
C20H32O2화학식
304.5 g/mol분자량
Mesterolone; Androviron; Proviron; 1424-00-6; Testiwop; SH 723; Mesterolona; Mesterolonum; 17beta-Hydroxy-1alpha-methyl-5alpha-androstan-3-one; SH-723; Pro-Viron; NSC-75054; 0SRQ75X9I9; DTXSID90878533; (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; Androstan-3-one, 17-hydroxy-1-methyl-, (1alpha,5alpha,17beta)-; NSC75054; 1alpha-methyl-5alpha-androstan-17beta-ol-3-one; (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-3-one; RefChem:389115; G03BB01; DTXCID101016578; 215-836-3; Mestoranum; Mesteranum; Mesterolon; 17-Hydroxy-1-methyl-5-androstane-3 one; SH-60723; NSC 75054; 1.alpha.-Methyl-5.alpha.-dihydrotestosterone; Androstan-3-one, 17-hydroxy-1-methyl-, (1.alpha.,5.alpha.,17.beta.)-; Mesterolonum [INN-Latin]; Mesterolona [INN-Spanish]; Provirone 25; Mesterolone (1.0mg/ml in Acetonitrile); Mesterolone [USAN:INN:BAN]; EINECS 215-836-3; 1alpha-Methyl-5alpha-dihydrotestosterone; UNII-0SRQ75X9I9; SH 60723; 5.alpha.-Androstan-3-one, 17.beta.-hydroxy-1.alpha.-methyl-; Mesterolone CRS; 1a-methyl-5a-dihydrotestosterone; Testosterone, 4,5alpha-dihydro-1alpha-methyl-; 1-alpha-Methyl-5-alpha-androstan-17-beta-ol-3-one; 1-alpha-Methyl-17-beta-hydroxy-5-alpha-androstan-3-one; 17-beta-Hydroxy-1-alpha-methyl-5-alpha-androstan-3-one; 5alpha-Androstan-3-one, 17beta-hydroxy-1alpha-methyl-; Androstan-3-one, 17-hydroxy-1-methyl-, (1a,5a,17b)-; MESTEROLONE [MI]; MESTEROLONE [INN]; Mesterolone (USAN/INN); MESTEROLONE [USAN]; EC 215-836-3; MESTEROLONE [MART.]; MESTEROLONE [WHO-DD]; 17.beta.-Hydroxy-1.alpha.-methyl-5.alpha.-androstan-3-one; SCHEMBL148260; CHEMBL258918; Mesterolone, analytical standard; MESTEROLONE [EP IMPURITY]; MSK8503; CHEBI:135293; MESTEROLONE [EP MONOGRAPH]; 5-alpha-ANDROSTAN-3-ONE, 17-beta-HYDROXY-1-alpha-METHYL-; Androstan-3-one, 17-hydroxy-1-methyl-, (1-alpha,5-alpha,17-beta)-; BDBM50423551; LMST02020107; MSK8503-100A; s3946; AKOS015894889; MSK8503-1000A; CCG-267514; DB13587; FM32442; Mesterolone 1.0 mg/ml in Acetonitrile; 1a-Methyl-5a-androstan-17b-ol-3-one; (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one; 11alpha-Methylandrostan-17beta-ol-3-one; 17b-hydroxy-1a-methyl-5a-Androstan-3-one; 1a-Methyl-17b-hydroxy-5a-androstan-3-one; NS00007289; D04947; Mesterolone Solution in Acetonitrile, 100ug/mL; Mesterolone Solution in Acetonitrile, 1000ug/mL; Mesterolone, 1.0 mg/mL in 1,2-dimethoxyethane; Testosterone,5.alpha.-dihydro-1.alpha.-methyl-; (1a,5a,17b)-17-hydroxy-1-methyl-Androstan-3-one; Androstan-3-one, (1.alpha.,5.alpha.,17.beta.)-; Q4291328; 1alpha-Methyl-5alpha-androstan-17beta-hydroxy-3-one; Mesterolone, European Pharmacopoeia (EP) Reference Standard; (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one동의어
